Abstract

Protection from viral infections depends on immunoglobulin isotype switching, which endows antibodies with effector functions. Here, we find that the protein kinase DYRK1A is essential for B cell-mediated protection from viral infection and effective vaccination through regulation of class switch recombination (CSR). Dyrk1a-deficient B cells are impaired in CSR activity in vivo and in vitro. Phosphoproteomic screens and kinase-activity assays identify MSH6, a DNA mismatch repair protein, as a direct substrate for DYRK1A, and deletion of a single phosphorylation site impaired CSR. After CSR and germinal center (GC) seeding, DYRK1A is required for attenuation of B cell proliferation. These findings demonstrate DYRK1A-mediated biological mechanisms of B cell immune responses that may be used for therapeutic manipulation in antibody-mediated autoimmunity.

Class switch recombination (CSR) is a process by which B cells switch their immunoglobulin isotype and develop pathogen-eliminating antibodies. Here, the authors show that a protein kinase DYRK1A is required for protection from viral infection through the regulation of CSR and effective clonal expansion.

Details

Title
B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation
Author
Stoler-Barak, Liat 1 ; Harris, Ethan 2 ; Peres, Ayelet 3   VIAFID ORCID Logo  ; Hezroni, Hadas 1 ; Kuka, Mirela 4 ; Di Lucia, Pietro 4 ; Grenov, Amalie 1   VIAFID ORCID Logo  ; Gurwicz, Neta 1 ; Kupervaser, Meital 5 ; Yip, Bon Ham 2 ; Iannacone, Matteo 6   VIAFID ORCID Logo  ; Yaari, Gur 3 ; Crispino, John D. 2   VIAFID ORCID Logo  ; Shulman, Ziv 1   VIAFID ORCID Logo 

 Weizmann Institute of Science, Department of Systems Immunology, Rehovot, Israel (GRID:grid.13992.30) (ISNI:0000 0004 0604 7563) 
 St. Jude Children’s Research Hospital, Department of Hematology, Memphis, USA (GRID:grid.240871.8) (ISNI:0000 0001 0224 711X) 
 Bar Ilan University, Faculty of Engineering, Ramat Gan, Israel (GRID:grid.22098.31) (ISNI:0000 0004 1937 0503) 
 Vita-Salute San Raffaele University and Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884) 
 Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, De Botton Institute for Proteomics, Rehovot, Israel (GRID:grid.13992.30) (ISNI:0000 0004 0604 7563) 
 Vita-Salute San Raffaele University and Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884); IRCCS San Raffaele Scientific Institute, Experimental Imaging Center, Milan, Italy (GRID:grid.18887.3e) (ISNI:0000000417581884) 
Pages
1462
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2787454494
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.